Clinical Trial Update: To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating stereotactic body radiotherapy for treating primary renal cell carcinoma tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Primary Tumor, Renal Cell Carcinoma | Phase 1 | Status: TERMINATED